UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer

International journal of molecular sciences, 2023-02, Vol.24 (5), p.4522

2023

Volltextzugriff (PDF)

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study

PloS one, 2012-05, Vol.7 (5), p.e36170-e36170

2012

Volltextzugriff (PDF)

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Nature communications, 2021-09, Vol.12 (1), p.5588-5588, Article 5588

2021

Volltextzugriff (PDF)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Oncogene, 2020-03, Vol.39 (10), p.2229-2230

2020

Volltextzugriff (PDF)

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Oncogene, 2018-10, Vol.37 (41), p.5585-5586

2018

Volltextzugriff (PDF)

Robust de novo pathway enrichment with KeyPathwayMiner 5 [version 1; peer review: 2 approved]

F1000 research, 2016, Vol.5, p.1531-1531

2016

Volltextzugriff (PDF)

Quantitative Phosphoproteomics of the Angiotensin AT2-Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and Apoptosis

Hypertension (Dallas, Tex. 1979), 2022-11, Vol.79 (11), p.2530-2541

2022

Volltextzugriff (PDF)

Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19

Clinical cancer research, 2024-05, Vol.30 (10), p.2286-2286

2024

Volltextzugriff (PDF)

Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC)

BMC research notes, 2011-10, Vol.4 (1), p.424-424, Article 424

2011

Volltextzugriff (PDF)

Arsenite Disrupts Zinc-Dependent TGFβ2-SMAD Activity During Murine Cardiac Progenitor Cell Differentiation

Toxicological sciences, 2015-12, Vol.148 (2), p.409-420

2015

Volltextzugriff (PDF)

From the Cover: Arsenic Induces Accumulation of α-Synuclein: Implications for Synucleinopathies and Neurodegeneration

Toxicological sciences, 2016-10, Vol.153 (2), p.271-281

2016

Volltextzugriff (PDF)

Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients

Breast cancer research and treatment, 2015-12, Vol.154 (3), p.483-494

2015

Volltextzugriff (PDF)

Correlation between circulating cell‐free PIK 3 CA tumor DNA levels and treatment response in patients with PIK 3 CA ‐mutated metastatic breast cancer

Molecular oncology, 2018-06, Vol.12 (6), p.925-935

2018

Volltextzugriff (PDF)

Effect of rejuvenation of blood on 2,3-diphosphoglycerate, hemoglobin-oxygen affinity and filtrability of red blood cells

Clinical hemorheology and microcirculation, 2016-12, Vol.5 (4), p.337-342

2016

Volltextzugriff (PDF)

Abstract 1415: Triple combination targeting ER, CDK4/6, and PI3K inhibits tumor growth in ER+ breast cancer resistant to combined fulvestrant and CDK4/6 or PI3K inhibitor

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1415-1415

2021

Volltextzugriff (PDF)

Macrophage CD5L is a target for cancer immunotherapyResearch in context

EBioMedicine, 2023-05, Vol.91, p.104555

2023

Volltextzugriff (PDF)

Quantitative Phosphoproteomics of the Angiotensin AT 2 -Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and Apoptosis

Hypertension (Dallas, Tex. 1979), 2022-11, Vol.79 (11), p.2530-2541

2022

Volltextzugriff (PDF)

Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure

The Journal of immunology (1950), 1995-01, Vol.154 (2), p.893-906

1995

Volltextzugriff (PDF)

Anti-C1q antibodies in SLE are the result of an antigen driven immune response

Molecular immunology, 2007-09, Vol.44 (16), p.3933-3934

2007

Volltextzugriff (PDF)

Rescue of a broader range of antibody specificities using an epitope-masking strategy

Methods in molecular biology (Clifton, N.J.), 2002, Vol.178, p.179

Ditzel, Henrik J

2002

Volltextzugriff (PDF)

Infrared spectroscopic study of absorption and separation of CO using copper(i)-containing ionic liquidsElectronic supplementary information (ESI) available: Plots of initial CO uptake rates and equilibrium ν(CO) intensity data from HPIR experiments. UV/visible spectra for assessment of trace [Cu(ii)]. Calibration plots for gas phase CO quantification. Synthetic procedures for CnmimX salts. See DOI: 10.1039/c6dt04816a

2017-02

Volltextzugriff (PDF)

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell lines

BMC proceedings, 2012-10, Vol.6 (S6), p.P35-P35, Article P35

2012

Volltextzugriff (PDF)

P-235 - Selective elimination of senescent cells by mitochondrial targeting is regulated via ANT2

Free radical biology & medicine, 2018-05, Vol.120, p.S116-S116

2018

Volltextzugriff (PDF)

Selective elimination of senescent cells by mitochondrial targeting is regulated via ANT2

Free radical biology & medicine, 2018-05, Vol.120, p.S116

2018

Volltextzugriff (PDF)

Abstract A2-17: High expression of CDK6 confers resistance to fulvestrant in breast cancer cells and is a potential predictor of fulvestrant treatment failure in estrogen receptor-positive breast cancer

Cancer research (Chicago, Ill.), 2015-11, Vol.75 (22_Supplement_1), p.A2-A2-17

2015

Volltextzugriff (PDF)

1 – 25 von 253

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(139)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Ugeskrift For Læger
(27)
The Lancet
(15)
Blood
(8)
Diabetologia
(7)
Nordisk Medicin
(7)
Cancer Research
(6)
Cheminform
(6)
Journal Of Geriatric Oncology
(6)
Acta Medica Scandinavica, Supplementum
(5)
Advances In Experimental Medicine And Biology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Robust de novo pathway enrichment with KeyPathwayMiner 5 [version 1; peer review: 2 approved]

Quantitative Phosphoproteomics of the Angiotensin AT2-Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and Apoptosis

Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19

Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC)

Arsenite Disrupts Zinc-Dependent TGFβ2-SMAD Activity During Murine Cardiac Progenitor Cell Differentiation

From the Cover: Arsenic Induces Accumulation of α-Synuclein: Implications for Synucleinopathies and Neurodegeneration

Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients

Correlation between circulating cell‐free PIK 3 CA tumor DNA levels and treatment response in patients with PIK 3 CA ‐mutated metastatic breast cancer

Effect of rejuvenation of blood on 2,3-diphosphoglycerate, hemoglobin-oxygen affinity and filtrability of red blood cells

Abstract 1415: Triple combination targeting ER, CDK4/6, and PI3K inhibits tumor growth in ER+ breast cancer resistant to combined fulvestrant and CDK4/6 or PI3K inhibitor

Macrophage CD5L is a target for cancer immunotherapyResearch in context

Quantitative Phosphoproteomics of the Angiotensin AT 2 -Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and Apoptosis

Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure

Anti-C1q antibodies in SLE are the result of an antigen driven immune response

Rescue of a broader range of antibody specificities using an epitope-masking strategy

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell lines

P-235 - Selective elimination of senescent cells by mitochondrial targeting is regulated via ANT2

Selective elimination of senescent cells by mitochondrial targeting is regulated via ANT2

Abstract A2-17: High expression of CDK6 confers resistance to fulvestrant in breast cancer cells and is a potential predictor of fulvestrant treatment failure in estrogen receptor-positive breast cancer

Aktive Filter

Suchergebnisse filtern